Mass Vaccination in a Pandemic - Benefits versus Risks: Interview with Geert Vanden Bossche

Mass Vaccination in a Pandemic - Benefits versus Risks: Interview with Geert Vanden Bossche

User Photo
admin

1 month
2 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

 

Geert Vanden Bossche PhD, is an internationally recognised vaccine developer having worked as the head of the Vaccine Development Office at the German Centre for Infection Research. Coordinated Global Alliance for Vaccines and Immunisation's Ebola Vaccine Program and contributed to the implementation of an integrated vaccine work plan in collaboration with Global Health Partners (WHO, Bill & Melinda Gates Foundation, CDC, UNICEF), regulators (FDA) and vaccine manufacturers to enable timely deployment or stockpiling of Ebola vaccine candidates. Sharing his perspective on mass vaccination in COVID-19. You can support us with a financial contribution through Patreon.

Access to more posts, podcasts and videos. https://patreon.com/VejonHealth Learn more about autoimmunity in COVID-19. https://mcmillanresearch.com/

Comments:

Comment
Up Next Autoplay
User Photo